MPR

Novo Nordisk Cuts Prices of Ozempic and Wegovy Starting January 2027

Novo Nordisk announced Tuesday that it will cut US list prices of Ozempic and Wegovy by up to 50% starting next year. The ...
MPR

Umeclidinium-Vilanterol Tied to Better Outcomes Than Other LAMA-LABA Inhalers in Symptomatic COPD

Findings based on comparison to glycopyrrolate-formoterol and tiotropium-olodaterol in patients newly prescribed LAMA-LABA inhalers.
MPR

Olezarsen Gets Priority Review for Severe Hypertriglyceridemia

The Food and Drug Administration (FDA) has granted Priority Review to the supplemental New Drug Application (sNDA) for olezarsen in the treatment of severe hypertriglyceridemia.
MPR

Efgartigimod Alfa–Hyaluronidase Improves Ocular Myasthenia Gravis Symptoms

Results from ADAPT OCULUS are expected to support a sBLA submission to the FDA to secure a label expansion for oMG.
MPR

COVID-19 Vaccination Protective Against Preeclampsia

HealthDay News — COVID-19 vaccination, especially with a booster dose, is associated with reduced odds of preeclampsia (PE), according to a study published online February 18 in eClinicalMedicine.
MPR

FDA Approves Desmoda Oral Solution for Central Diabetes Insipidus

Clinicians now have an FDA-approved liquid desmopressin option for central diabetes insipidus, designed for dosing consistency across the age spectrum.
MPR

Menopausal Hormone Therapy Not Linked to Increased Mortality Risk

Those who used menopausal hormone therapy had a 27 to 34% lower mortality hazard than those who did not. HealthDay News — Menopausal hormone therapy is not associated with an increased risk for ...